131 related articles for article (PubMed ID: 7822006)
21. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.
Kim J; Urban RG; Strominger JL; Wiley DC
Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880
[TBL] [Abstract][Full Text] [Related]
22. Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB.
Komisar JL; Small-Harris S; Tseng J
Infect Immun; 1994 Nov; 62(11):4775-80. PubMed ID: 7927754
[TBL] [Abstract][Full Text] [Related]
23. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
24. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
25. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
26. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
27. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway.
Haregewoin A; Edwin C; Hom RC; Finberg R
Immunol Invest; 1994 Nov; 23(6-7):413-20. PubMed ID: 7851959
[TBL] [Abstract][Full Text] [Related]
28. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
29. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
30. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
31. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
32. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
[TBL] [Abstract][Full Text] [Related]
33. Cytokine induction by Mycoplasma arthritidis-derived superantigen (MAS), but not by TSST-1 or SEC-3, is correlated to certain HLA-DR types.
Alvarez-Ossorio L; Johannsen M; Alvarez-Ossorio R; Nicklas W; Kirchner H; Rink L
Scand J Immunol; 1998 Jan; 47(1):43-7. PubMed ID: 9467657
[TBL] [Abstract][Full Text] [Related]
34. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
35. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
Mehindate K; al-Daccak R; Damdoumi F; Mourad W
Eur J Immunol; 1996 Sep; 26(9):2075-80. PubMed ID: 8814249
[TBL] [Abstract][Full Text] [Related]
37. Bacterial superantigens induce V beta-specific T cell receptor internalization.
Makida R; Hofer MF; Takase K; Cambier JC; Leung DY
Mol Immunol; 1996 Jul; 33(10):891-900. PubMed ID: 8845021
[TBL] [Abstract][Full Text] [Related]
38. Immune response to staphylococcal superantigens.
Krakauer T
Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
40. Bindings of toxic shock syndrome toxin-1 and staphylococcal enterotoxins A, B, and C to rabbit spleen cells.
Fujikawa H; Takayama H; Uchiyama T; Igarashi H
Microbiol Immunol; 1989; 33(5):381-90. PubMed ID: 2755362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
